These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4986717)

  • 1. In vitro assay of suppressive properties of antilymphocyte sera on lymphocyte stimulation.
    Revillard JP; Brochier J; Traeger J; Balner H
    Transplantation; 1970 Jun; 9(6):592-7. PubMed ID: 4986717
    [No Abstract]   [Full Text] [Related]  

  • 2. Testing of antihuman lymphocyte sera in chimpanzees and lower primates.
    Balner H; Dersjant H; Van Bekkum DW
    Transplantation; 1969 Sep; 8(3):281-90. PubMed ID: 4985395
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stimulating and inhibitory actions of antilymphocyte serums on human lymphocytes in culture].
    Revillard JP; Brochier J
    Lyon Med; 1970 Oct; 224(34):401-12. PubMed ID: 4991511
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of heterologous antilymphocyte serum on human lymphocyte cytotoxicity in vitro.
    Lundgren G
    Surg Forum; 1969; 20():241-3. PubMed ID: 5393626
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological effects of antithymus serum and antilymphocyte serum.
    Nagaya H; Sieker HO
    Prog Immunobiol Stand; 1970; 4():225-9. PubMed ID: 4098263
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies with anti-lymphocytic antibody and antibody-fragments.
    James K
    Prog Immunobiol Stand; 1970; 4():256-64. PubMed ID: 4394821
    [No Abstract]   [Full Text] [Related]  

  • 7. [Standardization of antilymphocyte serum].
    Balner H; Traeger J; van Bekkum DW; Carraz M; Fries D; Plan R; Brochier M; Triau R; Charbonnier C; Cotte J; Durix C; Bonneau M; Veyssere C; Prévot J
    Prog Immunobiol Stand; 1970; 4():214-24. PubMed ID: 4991584
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blastic transformation and DNA synthesis in lymphocyte cultures from patients with aplastic anemia (panmyelopathy)].
    Flad HD; Hochapfel G; Fliedner TM; Heimpel H
    Acta Haematol; 1970; 44(1):21-31. PubMed ID: 4991324
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunocompetent cells in man. II. Existence of distinct populations of circulating lymphocytes capable of responding to stimulation by phytohemagglutinin, antigen, antilymphocyte serum and allogeneic lymphocytes.
    Wu AS; Algom D; Richter M
    Pathol Microbiol (Basel); 1974; 41(1):1-10. PubMed ID: 4278134
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro actions of antilymphocyte sera.
    Bach FH; Bach ML
    Fed Proc; 1970; 29(1):130-2. PubMed ID: 5412391
    [No Abstract]   [Full Text] [Related]  

  • 11. The stimulating and suppressive properties of anti-lymphocyte serum (ALS) on lymphocyte transformation in vitro.
    Eijsvoogel VP; Schellekens PT; van Loghem JJ; Du Bois MJ
    Transplant Proc; 1969 Mar; 1(1):408-12. PubMed ID: 4944251
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigen-induced suppression of the in vitro lymphocyte response to different antigens and mitogens.
    Möller G; Kashiwagi N
    Immunology; 1972 Mar; 22(3):441-56. PubMed ID: 5026855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro cytotoxicity by human lymphocytes from individuals immunized against histocompatibility antigens. I. Kinetics and specificity of the reaction. Influence of metabolic inhibitors and anti-lymphocyte serum.
    Lundgren G
    Clin Exp Immunol; 1970 May; 6(5):661-70. PubMed ID: 4097827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of antilymphocyte serum.
    Mitchison NA
    Fed Proc; 1970; 29(1):222-3. PubMed ID: 5412394
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological testing of antilymphocyte sera and globulin in the baboon.
    Murphy GP; Brede HD; Schoonees R; Groenewald JH; Cohen E; Amiraian K; Moore GE
    J Surg Oncol; 1971; 3(2):169-83. PubMed ID: 4999300
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to phytohaemagglutinin of lymphocytes from mice treated with anti-lymphocyte globulin.
    Tursi A; Greaves MF; Torrigiani G; Playfair JH; Roitt IM
    Immunology; 1969 Nov; 17(5):801-11. PubMed ID: 4900922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of delayed hypersensitivity in immunological processes and its relationship to aphthous stomatitis.
    Oppenheim JJ; Francis TC
    J Periodontol; 1970 Apr; 41(4):205-9. PubMed ID: 4194166
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of anti-lymphocyte globulins made from thoracic duct lymphocytes.
    Traeger J; Carraz M; Fries D; Perrin J; Saubier E; Bernhardt JP; Revillard JP; Bonnet P; Archimbaud JP; Brochier J
    Transplant Proc; 1969 Mar; 1(1):455-9. PubMed ID: 4332532
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in the in vitro induction of thymidine-3H uptake into leukemic lymphoblasts by phytohemagglutinin and heterologous antithymocyte sera.
    Necheles TF; Silverman E; Allen DM
    Proc Soc Exp Biol Med; 1970 Jul; 134(3):738-40. PubMed ID: 5270343
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte activation. II. discriminating stimulation of lymphocyte subpopulations by phytomitogens and heterologous antilymphocyte sera.
    Janossy G; Greaves MF
    Clin Exp Immunol; 1972 Mar; 10(3):525-36. PubMed ID: 5033804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.